Tectonic Therapeutic, Inc.
TECX
$32.64
-$0.67-2.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.00% | 4.75% | -25.64% | -28.55% | 30.16% |
| Total Depreciation and Amortization | -2.63% | 0.59% | -5.56% | -29.13% | 19.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.67% | 8.61% | 21.35% | 303.40% | -66.91% |
| Change in Net Operating Assets | 134.87% | -246.43% | 1,260.93% | 97.31% | -31.27% |
| Cash from Operations | 18.83% | -21.03% | -12.50% | 22.22% | 14.20% |
| Capital Expenditure | 100.00% | -- | 100.00% | -800.00% | 98.04% |
| Sale of Property, Plant, and Equipment | -100.00% | -72.73% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -401.82% | 303.70% | -800.00% | 98.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.25% | -1.65% | -2.54% | -2.61% | 4.17% |
| Issuance of Common Stock | 883.33% | -99.92% | -95.54% | 19,726.47% | 1,067.53% |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 78.53% | 97.16% | -- | -- | 70.32% |
| Cash from Financing | 69.15% | 89.04% | -102.34% | 16,762.49% | 83.00% |
| Foreign Exchange rate Adjustments | -52.17% | 28.13% | -540.00% | -113.51% | 146.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.71% | 2.14% | -111.43% | 1,024.10% | 31.40% |